Symmetry Partners’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,371
Closed -$479K 636
2020
Q4
$479K Sell
2,371
-579
-20% -$120K 0.04% 384
2020
Q3
$620K Buy
2,950
+1,034
+54% +$230K 0.05% 262
2020
Q2
$420K Buy
+1,916
New +$383K 0.05% 182
2019
Q4
Sell
-2,939
Closed -$446K 335
2019
Q3
$446K Sell
2,939
-148
-5% -$23.4K 0.09% 179
2019
Q2
$473K Buy
3,087
+165
+6% +$25.2K 0.1% 167
2019
Q1
$469K Buy
2,922
+2,746
+1,560% +$426K 0.08% 163
2018
Q4
$27K Buy
+176
New +$27.4K 0.01% 370

Other funds holding CLX

Symmetry Partners's CLX Position: Q1 2021 in Review

Symmetry Partners sold out of Clorox (CLX) in Q1 2021, closing a stake of 2,371 shares — an estimated $479K sold.

Symmetry Partners first reported a position in CLX in Q4 2018 and held it in 7 quarters. The position peaked at $620K in Q3 2020. 1,207 funds tracked by Wall St. Rank hold CLX as of Q1 2021.

  • Symmetry Partners reported no remaining Clorox position as of Q1 2021 after selling out during the quarter.
  • Symmetry Partners sold 2,371 Clorox shares in Q1 2021, an estimated $479K.
  • Symmetry Partners first reported a position in Clorox in Q4 2018 and held it in 7 quarters.
  • Symmetry Partners's Clorox position peaked at $620K in Q3 2020.
  • 1,207 funds tracked by Wall St. Rank held Clorox as of Q1 2021.

Based on Symmetry Partners's 13F filing for Q1 2021, filed 3 May 2021.